YL II A LIMITED

Company number 14285867 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

YL II A LIMITED - Analysis Report

Company Number: 14285867

Analysis Date: 2025-07-19 12:21 UTC

Financial Health Assessment of YL II A LIMITED
Period Ending: 31 December 2023


1. Financial Health Score: C

Explanation:
YL II A LIMITED exhibits mixed financial health indicators. The company has a substantial turnover (£32.2M) and strong cash reserves (£9.56M), which are positive signs of liquidity and revenue generation. However, it reports negative net assets (-£252k), indicating a deficit in shareholders’ funds and potential balance sheet weakness. The company is undergoing a significant business model transition, which adds complexity and risk. Accounting qualification on interest income recognition also introduces uncertainty. Overall, the company shows symptoms of financial stress but retains liquidity support and a clear strategic pivot, warranting a mid-level grade.


2. Key Vital Signs and Interpretation

Metric Value Interpretation
Turnover £32,195,942 Indicates strong revenue generation for a young company, reflecting robust business activity.
Current Assets £9,562,974 Healthy short-term asset base, primarily cash, indicating good liquidity ("healthy cash flow").
Cash £9,562,874 Almost entire current assets are cash, a positive sign for meeting immediate obligations.
Debtors £100 Negligible trade receivables, consistent with the sale of loan book and shift in business model.
Current Liabilities £9,815,129 High short-term liabilities almost matching cash, suggesting tight working capital management.
Net Assets -£252,155 Negative net assets signal that liabilities exceed assets, a "symptom of underlying distress".
Shareholders’ Funds -£252,255 Negative equity, indicating cumulative losses or capital erosion.
Profit/Loss Net loss approx. £252k Company reported a net loss, partly due to exceptional loss on disposal of loan book and accounting policies.

Additional Observations:

  • The company sold its Merchant Cash Advance loan book in July 2023, realizing a large exceptional loss (£18.99M) but also recognized exceptional income related to loan waivers from its parent company.
  • The auditor qualified the opinion due to incorrect accounting treatment of interest income, resulting in overstatement of both income and disposal loss, though net loss remains unaffected.
  • Going concern is supported by the parent company’s commitment to fund any deficits, which is critical given the negative equity position.
  • The business model is shifting from direct lending to loan arrangement and introduction to a securitisation vehicle, reducing credit risk but also transforming revenue sources.

3. Diagnosis: Overall Financial Condition

YL II A LIMITED is in a transitional phase, moving away from direct lending with inherent credit risk to acting as an intermediary for a securitisation vehicle. This strategic pivot reduces operational and credit risk exposure but also marks a significant shift in business dynamics.

Despite a strong cash position ("healthy cash flow"), the balance sheet shows symptoms of distress with negative net assets and shareholders’ funds. This is largely due to the exceptional loss incurred on disposal of the loan book and accumulated losses since incorporation.

The auditor’s qualified opinion on revenue recognition introduces some uncertainty in reported earnings, suggesting management should improve accounting policies to align with standards and enhance financial transparency.

The company’s liquidity is currently stable, supported by cash and the financial backing of its parent, which is critical for sustaining operations given the negative equity.

In summary, YL II A LIMITED’s financial health shows resilience in liquidity and revenue generation but weakness in capital structure and profitability. The company depends on parent support and successful execution of its new business model for future stability.


4. Recommendations to Improve Financial Wellness

  • Accounting Policy Alignment: Revise interest income recognition to comply with Financial Reporting Standard 102, using the effective interest rate method. This will improve accuracy and credibility of financial reporting.
  • Strengthen Capital Base: Consider capital injection or restructuring to eliminate negative net assets, restoring balance sheet strength and investor confidence.
  • Enhance Risk Management: Continue to monitor and manage operational risks related to the new business model, especially dependencies on third parties such as Youlend Limited and the securitisation vehicle.
  • Improve Profitability: Focus on developing fee income from loan arrangement and introduction services, diversifying revenue streams beyond interest income.
  • Maintain Strong Liquidity: Preserve cash reserves and maintain close coordination with the parent company for ongoing funding commitments, ensuring smooth operations and meeting liabilities.
  • Transparent Communication: Provide clear disclosures to stakeholders on the business transition, exceptional items, and accounting policies to build trust and reduce uncertainty.

Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 19 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.